SM-Youtube

Year	Number of Results
1967	1
1969	6
1970	5
1971	4
1972	4
1973	7
1974	5
1975	7
1976	4
1977	12
1978	5
1979	14
1980	12
1981	7
1982	17
1983	18
1984	19
1985	10
1986	9
1987	16
1988	5
1989	9
1990	10
1991	11
1992	8
1993	8
1994	11
1995	11
1996	8
1997	7
1998	10
1999	12
2000	13
2001	16
2002	17
2003	28
2004	32
2005	26
2006	37
2007	45
2008	39
2009	26
2010	28
2011	33
2012	50
2013	48
2014	48
2015	69
2016	64
2017	50
2018	45
2019	51
2020	46
2021	36
2022	10
2023	2
2024	38

Year

Number of Results

1967

1969

1970

1971

1972

1973

1974

1975

1976

1977

1978

1979

1980

1981

1982

1983

1984

1985

1986

1987

1988

1989

1990

1991

1992

1993

1994

1995

1996

1997

1998

1999

2000

2001

2002

2003

2004

2005

2006

2007

2008

2009

2010

2011

2012

2013

2014

2015

2016

2017

2018

2019

2020

2021

2022

2023

2024

Page 1

Identifying benign and malignant thyroid nodules based on blood serum surface-enhanced Raman spectroscopy.

Xia L, Lu J, Chen Z, Cui X, Chen S, Pei D. Xia L, et al. Nanomedicine. 2021 Feb;32:102328. doi: 10.1016/j.nano.2020.102328. Epub 2020 Nov 10. Nanomedicine. 2021. PMID: 33181274

Blood prognostic predictors of treatment response for patients with papillary thyroid cancer.

Liu X, Huang Z, He X, Zheng X, Jia Q, Tan J, Fan Y, Lou C, Meng Z. Liu X, et al. Biosci Rep. 2020 Oct 30;40(10):BSR20202544. doi: 10.1042/BSR20202544. Biosci Rep. 2020. PMID: 33015713 Free PMC article.

Effect of ¹³¹I Therapy on Complete Blood Count in Patients with Differentiated Thyroid Cancer.

Rui Z, Wu R, Zheng W, Wang X, Meng Z, Tan J. Rui Z, et al. Med Sci Monit. 2021 Feb 11;27:e929590. doi: 10.12659/MSM.929590. Med Sci Monit. 2021. PMID: 33568620 Free PMC article.

Radioiodine therapy accelerates apoptosis in peripheral blood lymphocytes of patients with differentiated thyroid cancer.

Vrndic O, Milosevic-Djordjevic O, Djurdjevic P, Jovanovic D, Mijatovic L, Jeftic I, Simonovic SZ. Vrndic O, et al. Neoplasma. 2013;60(5):568-75. doi: 10.4149/neo_2013_074. Neoplasma. 2013. PMID: 23790177 Clinical Trial.

Human kallikrein 2 (hK2) mRNA in peripheral blood of patients with thyroid cancer: a novel molecular marker?

Roddiger SJ, Renneberg H, Martin T, Tunn UW, Zamboglou N, Kurek R. Roddiger SJ, et al. J Cancer Res Clin Oncol. 2003 Jan;129(1):29-34. doi: 10.1007/s00432-002-0401-y. Epub 2003 Feb 12. J Cancer Res Clin Oncol. 2003. PMID: 12618898

Promising molecular techniques for discriminating among follicular thyroid neoplasms.

Carroll NM, Carty SE. Carroll NM, et al. Surg Oncol. 2006 Aug;15(2):59-64. doi: 10.1016/j.suronc.2006.07.003. Epub 2006 Sep 1. Surg Oncol. 2006. PMID: 16949814 Review.

Systemic alterations in phospholipid concentrations of blood plasma in patients with thyroid carcinoma: an in-vitro (31)P high-resolution NMR study.

Raffelt K, Moka D, Süllentrop F, Dietlein M, Hahn J, Schicha H. Raffelt K, et al. NMR Biomed. 2000 Jan;13(1):8-13. doi: 10.1002/(sici)1099-1492(200002)13:1<8::aid-nbm602>3.0.co;2-x. NMR Biomed. 2000. PMID: 10668049

Serum biomarkers for thyroid cancer.

Xiao Q, Jia Q, Tan J, Meng Z. Xiao Q, et al. Biomark Med. 2020 Jun;14(9):807-815. doi: 10.2217/bmm-2019-0578. Epub 2020 Jul 17. Biomark Med. 2020. PMID: 32677454 Review.

Vitamin D in thyroid disorders.

Kmieć P, Sworczak K. Kmieć P, et al. Exp Clin Endocrinol Diabetes. 2015 Jul;123(7):386-93. doi: 10.1055/s-0035-1554714. Epub 2015 Jul 14. Exp Clin Endocrinol Diabetes. 2015. PMID: 26171622 Review.

Thyroglobulin in differentiated thyroid cancer.

Evans C, Tennant S, Perros P. Evans C, et al. Clin Chim Acta. 2015 Apr 15;444:310-7. doi: 10.1016/j.cca.2014.10.035. Epub 2014 Oct 29. Clin Chim Acta. 2015. PMID: 25444737 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

1,075 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Search Results

1,075 results

Results by year